Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Adolescents With ADHD
Public ClinicalTrials.gov record NCT03247556. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) 400 and 600 mg Efficacy and Safety in Adolescents With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the efficacy and safety of high doses of SPN-812 in adolescents (12-17 years old) with ADHD
Study identification
- NCT ID
- NCT03247556
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 297 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 19, 2017
- Primary completion
- Feb 13, 2019
- Completion
- Feb 13, 2019
- Last update posted
- Jul 1, 2021
2017 – 2019
United States locations
- U.S. sites
- 14
- U.S. states
- 8
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alliance for Wellness dba Alliance for Research | Long Beach | California | 90807 | — |
| MCB Clinical Research Centers, LLC | Colorado Springs | Colorado | 80910 | — |
| Meridien Research at Florida Clinical Research Center | Bradenton | Florida | 34201 | — |
| Innovative Clinical Research, Inc | Lauderhill | Florida | 33319 | — |
| Miami Clinical Research | Miami | Florida | 33155 | — |
| APG Research, LLC | Orlando | Florida | 32803 | — |
| iResearch Atlanta | Decatur | Georgia | 30030 | — |
| IPS Research | Oklahoma City | Oklahoma | 73103 | — |
| Paradigm Research Professionals | Oklahoma City | Oklahoma | 73118 | — |
| Carolina Clinical Trials, Inc. | Charleston | South Carolina | 29407 | — |
| Gadolin Research, LLC | Beaumont | Texas | 77702 | — |
| Bayou City Research Corporation | Houston | Texas | 77006 | — |
| Discovery MM Services Inc. Houston | Houston | Texas | 77061 | — |
| Ericksen Research & Development | Clinton | Utah | 84015 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated ADHD trials
Other public records listing ADHD. Sorted by last update posted; newest first. Not a recommendation.
- NCT07784348: Evaluating the Efficacy of Central Executive Training (CET) For Young Children With ADHD Recruiting
- NCT07717892: A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With ADHD Recruiting
- NCT07717879: A Study to Assess the Efficacy and Safety of Solriamfetol in Children With ADHD Recruiting
- NCT07661823: QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428 Not yet recruiting
- NCT07684417: Impact of Short and Mistimed Sleep on Adolescents With ADHD: The Adolescent Attention and Circadian Timing Study Not yet recruiting
- NCT04526600: Fidgeting and Attentional and Emotional Regulation in ADHD Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03247556, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 1, 2021 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03247556 live on ClinicalTrials.gov.